Oxycodon-Hcl/Naloxon-Hcl Puren (Oxycodone Hydrochloride, Naloxone Hydrochloride Dihydrate)

Oxycodone Hydrochloride, the active ingredient in Oxycodon-Hcl/Naloxon-Hcl Puren, is an opioid analgesic presented as a combination formulation for oral use. It is used to treat moderate to severe pain in adult patients when other analgesics are insufficient.

GNH USA supplies Oxycodon-Hcl/Naloxon-Hcl Puren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycodon-Hcl/Naloxon-Hcl Puren is an opioid analgesic indicated for pain management pathways involving strong opioid receptors. - Acute postoperative pain: provides rapid relief of moderate to severe pain following surgery. - Cancer‑related pain: helps control persistent pain associated with malignant disease. - Chronic non‑cancer pain: used when other treatments have failed to achieve adequate analgesia.

Adverse reactions may occur with opioid therapy and should be monitored.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Constipation: reduced bowel motility. - Dizziness: light‑headed feeling. - Somnolence: increased sleepiness. - Dry mouth: reduced salivation. - Pruritus: mild skin itching.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure. - Acute adrenal insufficiency: rare hormonal imbalance. - Allergic reactions: rash, swelling, or anaphylaxis. - Opioid use disorder: risk of dependence or misuse. - Withdrawal syndrome: symptoms if opioid therapy is abruptly stopped.

When prescribing Oxycodon-Hcl/Naloxon-Hcl Puren, clinicians should consider several safety measures. - Assess pain severity: confirm that opioid therapy is appropriate. - Evaluate respiratory function: monitor patients with COPD or sleep apnea. - Review medication history: avoid concurrent CNS depressants when possible. - Monitor for signs of dependence: educate patients on proper use. - Adjust dose in renal/hepatic impairment: use lower initial doses. - Store at ambient temperature: keep in original container, protect from moisture and light.

Oxycodon-Hcl/Naloxon-Hcl Puren can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines, barbiturates): may cause profound respiratory depression. - MAO inhibitors: increase risk of serotonin syndrome. - Strong CYP3A4 inhibitors (e.g., ketoconazole): elevate oxy‑dose plasma levels.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine): may alter oxycodone metabolism. - Diuretics: can enhance hypotensive effects. - Anticholinergics: may worsen constipation. - Alcohol: additive CNS depression. - Herbal supplements (e.g., St John’s wort): may affect opioid metabolism.